amylon.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://amylon.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Amylon- Developing medicines for patients with unmet medical
Description RNA Modulation Amylon Therapeutics is a biotechnology company dedicated to developing therapies for rare genetic disorders of the central nervous
Keywords N/A
Server Information
WebSite amylon faviconamylon.com
Host IP 185.218.164.50
Location -
Related Websites
Site Rank
More to Explore
amylon.com Valuation
US$2,329,782
Last updated: 2023-05-09 01:34:09

amylon.com has Semrush global rank of 4,543,045. amylon.com has an estimated worth of US$ 2,329,782, based on its estimated Ads revenue. amylon.com receives approximately 268,821 unique visitors each day. Its web server is located in -, with IP address 185.218.164.50. According to SiteAdvisor, amylon.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,329,782
Daily Ads Revenue US$2,151
Monthly Ads Revenue US$64,518
Yearly Ads Revenue US$774,205
Daily Unique Visitors 17,922
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
amylon.com. A 300 IP: 185.218.164.50
amylon.com. NS 86400 NS Record: ns2.transip.eu.
amylon.com. NS 86400 NS Record: ns0.transip.net.
amylon.com. NS 86400 NS Record: ns1.transip.nl.
amylon.com. MX 300 MX Record: 0 amylon-com.mail.protection.outlook.com.
amylon.com. TXT 300 TXT Record: v=spf1 ip4:192.166.96.1/24 ip4:109.109.120.1/24 ip4:109.109.96.1/24 a:spf.spamexperts.registrar.eu include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-09 01:34:09
Amylon About Amylon The Team Science Technology Pipeline HCHWA-D News Careers Contact Select Page RNA Modulation Technology Amylon’s drug development platform is based on our innovative RNA Modulation Technology. RNA Modulation Technology uses antisense oligonucleotides (ASOs) to alter the splicing of pre-mRNA to counteract the effects of disease-causing mutations. Learn More Amylon Therapeutics Amylon Therapeutics is a biotechnology company dedicated to developing therapies for rare genetic disorders of the central nervous system. Amylon is led by a strong management team of entrepreneurs and industry veterans, complemented by a world-class supervisory- and scientific advisory board. Pipeline Amylon has several therapeutic programs in its pipeline. Our lead research program targets the disorder Hereditary Cerebral Hemorrhage with Amyloidosis Dutch Type (HCHWA-D), also referred to as Katwijk’s disease, the most common form of hereditary cerebral amyloid angiopathy (CAA). Learn More
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sun, 31 Oct 2021 01:09:50 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://amylon.com/

HTTP/2 200 
server: nginx
date: Sun, 31 Oct 2021 01:09:51 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
x-powered-by: PHP/7.4.25
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
x-cache-status: MISS
x-powered-by: PleskLin
amylon.com Whois Information
Domain Name: AMYLON.COM
Registry Domain ID: 1605154587_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.rrpproxy.net
Registrar URL: http://www.key-systems.net
Updated Date: 2021-07-22T15:14:49Z
Creation Date: 2010-07-05T18:35:10Z
Registry Expiry Date: 2022-07-05T18:35:10Z
Registrar: Key-Systems GmbH
Registrar IANA ID: 269
Registrar Abuse Contact Email: abuse@key-systems.net
Registrar Abuse Contact Phone: +49.68949396850
Domain Status: ok https://icann.org/epp#ok
Name Server: NS0.TRANSIP.NET
Name Server: NS1.TRANSIP.NL
Name Server: NS2.TRANSIP.EU
DNSSEC: signedDelegation
DNSSEC DS Data: 34623 13 2 1FE0CF874CE8CCC844661FA79A96625E82F95135C6BCD04B157448C47EB3EBBC
>>> Last update of whois database: 2021-09-18T11:21:46Z <<<